Venus Concept Inc. (NASDAQ:VERO – Get Free Report) saw a significant increase in short interest in October. As of October 31st, there was short interest totalling 1,450,000 shares, an increase of 1,956.7% from the October 15th total of 70,500 shares. Approximately 35.1% of the shares of the stock are short sold. Based on an average daily trading volume, of 1,690,000 shares, the days-to-cover ratio is presently 0.9 days.
Insider Activity at Venus Concept
In other news, major shareholder Michael Willingham Masters sold 94,553 shares of the stock in a transaction that occurred on Wednesday, October 2nd. The shares were sold at an average price of $0.53, for a total transaction of $50,113.09. Following the sale, the insider now directly owns 17,059 shares of the company’s stock, valued at $9,041.27. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 57.98% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On Venus Concept
An institutional investor recently raised its position in Venus Concept stock. Masters Capital Management LLC lifted its position in Venus Concept Inc. (NASDAQ:VERO – Free Report) by 100.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 666,702 shares of the company’s stock after acquiring an additional 333,366 shares during the period. Masters Capital Management LLC owned approximately 10.49% of Venus Concept worth $522,000 at the end of the most recent quarter. 87.41% of the stock is owned by institutional investors and hedge funds.
Venus Concept Trading Down 7.4 %
Venus Concept (NASDAQ:VERO – Get Free Report) last issued its earnings results on Tuesday, August 13th. The company reported ($1.39) EPS for the quarter. The business had revenue of $16.58 million for the quarter. On average, sell-side analysts anticipate that Venus Concept will post -6.37 earnings per share for the current year.
About Venus Concept
Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.
Featured Stories
- Five stocks we like better than Venus Concept
- Using the MarketBeat Stock Split Calculator
- 3 Solar Stocks at Bargain Prices: Big Opportunities Ahead
- 3 Warren Buffett Stocks to Buy Now
- Is Bitcoin’s Trump Card a Boom or Bust?
- How to Evaluate a Stock Before Buying
- Cloudflare Is a Solid Buy for 2025
Receive News & Ratings for Venus Concept Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venus Concept and related companies with MarketBeat.com's FREE daily email newsletter.